NicOx To Reacquire From Pfizer Rights To Experimental Glaucoma Drug

Ophthalmology Times

NicOx announced an agreement to reacquire the development and commercialization rights to an experimental glaucoma medicine from partner company Pfizer.
  • <<
  • >>

Comments